BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Zaltman C, Parra RS, Sassaki LY, Santana GO, Ferrari MLA, Miszputen SJ, Amarante HMBS, Kaiser Junior RL, Flores C, Catapani WR, Parente JML, Bafutto M, Ramos O, Gonçalves CD, Guimaraes IM, da Rocha JJR, Feitosa MR, Feres O, Saad-Hossne R, Penna FGC, Cunha PFS, Gomes TN, Nones RB, Faria MAG, Parente MPPD, Scotton AS, Caratin RF, Senra J, Chebli JM. Real-world disease activity and sociodemographic, clinical and treatment characteristics of moderate-to-severe inflammatory bowel disease in Brazil. World J Gastroenterol 2021; 27(2): 208-223 [PMID: 33510560 DOI: 10.3748/wjg.v27.i2.208]
URL: https://www.wjgnet.com/1007-9327/full/v27/i2/208.htm
Number Citing Articles
1
Jian Wan, Jun Shen, Xiaoping Wu, Jie Zhong, Yan Chen, Lanxiang Zhu, Yinglei Miao, Naizhong Hu, Jie Chen, Jie Liang, Kaichun Wu. Geographical heterogeneity in the disease characteristics and management of patients with inflammatory bowel disease, the preliminary results of a Chinese database for IBD (CHASE-IBD)Therapeutic Advances in Gastroenterology 2023; 16 doi: 10.1177/17562848231210367
2
Gilmara Pandolfo Zabot, Ornella Sari Cassol, Eduardo Garcia Vilela, Antônio José Tibúrcio Alves Junior, Daniel de Castilho da Silva, Rogério Saad-Hossne. Profile of Surgeons Who Treat Inflammatory Bowel Diseases in BrazilJournal of Coloproctology 2024; 44(01): e53 doi: 10.1055/s-0044-1782153
3
Abel B. Quaresma, Aderson O.M.C. Damiao, Claudio S.R. Coy, Daniela O. Magro, Adriano A.F. Hino, Douglas A. Valverde, Remo Panaccione, Stephanie B. Coward, Siew C. Ng, Gilaad G. Kaplan, Paulo G. Kotze. Temporal trends in the epidemiology of inflammatory bowel diseases in the public healthcare system in Brazil: A large population-based studyThe Lancet Regional Health - Americas 2022; 13: 100298 doi: 10.1016/j.lana.2022.100298
4
Michele A. Serafini, Ana H. Paz, Natalia S. Nunes. Cholinergic immunomodulation in inflammatory bowel diseasesBrain, Behavior, & Immunity - Health 2022; 19: 100401 doi: 10.1016/j.bbih.2021.100401
5
Julio Maria Fonseca Chebli, Rogério Serafim Parra, Cristina Flores, Antonio Carlos Moraes, Rodrigo Bremer Nones, Tarcia Nogueira Ferreira Gomes, Ana Maria Bravo Perdomo, Gustavo Scapini, Cyrla Zaltman. Effectiveness and Safety of Ustekinumab for Moderate to Severely Active Crohn’s Disease: Results from an Early Access Program in BrazilJournal of Clinical Medicine 2022; 11(21): 6481 doi: 10.3390/jcm11216481
6
Rogério Serafim Parra, Júlio Maria Fonseca Chebli, Natália Sousa Freitas Queiroz, Aderson Omar Mourão Cintra Damião, Matheus Freitas Cardoso de Azevedo, Liliana Andrade Chebli, Erika Ruback Bertges, Antonio José Tiburcio Alves Junior, Orlando Ambrogini Junior, Bianca Loyo Pona Schiavetti da Silva, Marcio Lubini, Mauro Bafutto, Cristina Flores, Eduardo Garcia Vilela, Sandra Felice Boratto, Newton Luiz Tricarico Gasparetti Junior, Flavio Steinwurz, Nayara Salgado Carvalho, Omar Féres, José Joaquim Ribeiro da Rocha. Long-term effectiveness and safety of ustekinumab in bio-naïve and bio-experienced anti-tumor necrosis factor patients with Crohn’s disease: a real-world multicenter Brazilian studyBMC Gastroenterology 2022; 22(1) doi: 10.1186/s12876-022-02280-3
7
Carolina da Silva Beda Sacramento, Marina Pamponet Motta, Candida de Oliveira Alves, Jaciane Araujo Mota, Lina Maria Goes de Codes, Reginaldo Freitas Ferreira, Pedro de Almeida Silva, Larissa do Prado Palmiro, Rafael Miranda Barbosa, Mariana Nery Andrade, Vitor Damasceno Andrade, Vitor Brandão Vasconcelos, Bernardo Wasconcellos Thiara, Eduardo Martins Netto, Genoile Oliveira Santana. Variables associated with progression of moderate-to-severe Crohn’s diseaseBMJ Open Gastroenterology 2022; 9(1): e001016 doi: 10.1136/bmjgast-2022-001016
8
Renata de Sá Brito Fróes, Adriana Ribas Andrade, Mikaell Alexandre Gouvea Faria, Heitor Siffert Pereira de Souza, Rogério Serafim Parra, Cyrla Zaltman, Carlos Henrique Marques dos Santos, Mauro Bafutto, Abel Botelho Quaresma, Genoile Oliveira Santana, Rafael Luís Luporini, Sérgio Figueiredo de Lima Junior, Sender Jankiel Miszputen, Mardem Machado de Souza, Giedre Soares Prates Herrerias, Roberto Luiz Kaiser Junior, Catiane Rios do Nascimento, Omar Féres, Jaqueline Ribeiro de Barros, Ligia Yukie Sassaki, Rogerio Saad-Hossne. Clinical factors associated with severity in patients with inflammatory bowel disease in Brazil based on 2-year national registry data from GEDIIBScientific Reports 2024; 14(1) doi: 10.1038/s41598-024-54332-1
9
Abel Botelho QUARESMA, Ludmila Resende GUEDES, Jaqueline Ribeiro de BARROS, Júlio Pinheiro BAIMA, Marcello IMBRIZI, Marco Antônio ZERÔNCIO, Paulo Gustavo KOTZE, Cristina FLORES. STRUCTURAL EVALUATION OF INFLAMMATORY BOWEL DISEASE COMPREHENSIVE CARE UNITS IN BRAZILArquivos de Gastroenterologia 2024; 61 doi: 10.1590/s0004-2803.24612023-166
10
Ligia Yukie Sassaki, Sender J Miszputen, Roberto Luiz Kaiser Junior, Wilson R Catapani, Mauro Bafutto, António S Scotton, Cyrla Zaltman, Julio Pinheiro Baima, Hagata S Ramos, Mikaell Alexandre Gouvea Faria, Carolina D Gonçalves, Isabella Miranda Guimaraes, Cristina Flores, Heda M B S Amarante, Rodrigo Bremer Nones, José Miguel Luz Parente, Murilo Moura Lima, Júlio Maria Chebli, Maria de Lourdes Abreu Ferrari, Julia F Campos, Maria G P Sanna, Odery Ramos, Rogério Serafim Parra, Jose J R da Rocha, Omar Feres, Marley R Feitosa, Rosana Fusaro Caratin, Juliana Tosta Senra, Genoile Oliveira Santana. Real-world treatment patterns and disease control over one year in patients with inflammatory bowel disease in BrazilWorld Journal of Gastroenterology 2021; 27(23): 3396-3412 doi: 10.3748/wjg.v27.i23.3396
11
Eduard Brunet, Emili Vela, Luigi Melcarne, Laura-Patricia Llovet, Anna Puy, Montserrat Clèries, Caridad Pontes, Pilar García-Iglesias, Albert Villòria, Gilaad G. Kaplan, Xavier Calvet. Heterogeneity in pharmacological treatment and outcomes in Crohn’s disease patients in Catalonia: a population-based observational studyAnnals of Medicine 2022; 54(1): 1255 doi: 10.1080/07853890.2022.2069851
12
Bingzhou Bao, Chao Zhu, Jian Shi, Canxing Lu. Causal association between inflammatory bowel disease and hidradenitis suppurativa: A two-sample bidirectional Mendelian randomization studyFrontiers in Immunology 2023; 14 doi: 10.3389/fimmu.2023.1071616